Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CAH
stocks logo

CAH

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
60.74B
+1.46%
1.959
+6.46%
59.16B
+13.17%
2.125
+13.04%
61.53B
+11.34%
2.158
+11.79%
Estimates Revision
The market is revising Upward the revenue expectations for Cardinal Health, Inc. (CAH) for FY2025, with the revenue forecasts being adjusted by 0.08% over the past three months. During the same period, the stock price has changed by 26.82%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.08%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.15%
In Past 3 Month
Stock Price
Go Up
up Image
+26.82%
In Past 3 Month
12 Analyst Rating
up Image0
Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 171.42 USD with a low forecast of 156.00 USD and a high forecast of 183.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
2 Hold
0 Sell
Strong Buy
up Image0
Current: 164.910
sliders
Low
156.00
Averages
171.42
High
183.00
up Image0
Current: 164.910
sliders
Low
156.00
Averages
171.42
High
183.00
Citi
Daniel Grosslight
Neutral
maintain
$157 -> $170
2025-06-13
New
Reason
Citi
Daniel Grosslight
Price Target
$157 -> $170
2025-06-13
New
maintain
Neutral
Reason
Citi analyst Daniel Grosslight raised the firm's price target on Cardinal Health to $170 from $157 and keeps a Neutral rating on the shares. The company's investor day showcased the significant progress it has made in bolstering its specialty solutions and accelerating its non-pharma growth areas, the analyst tells investors in a research note.
Morgan Stanley
Erin Wright
Overweight
maintain
$166 -> $181
2025-06-13
New
Reason
Morgan Stanley
Erin Wright
Price Target
$166 -> $181
2025-06-13
New
maintain
Overweight
Reason
Morgan Stanley analyst Erin Wright raised the firm's price target on Cardinal Health (CAH) to $181 from $166 and keeps an Overweight rating on the shares. Cardinal raised its FY25 guidance with only a few weeks left in the year, attributable to broad-based industry tailwinds, seemingly consistent with McKesson (MCK) commentary early this week, the analyst tells investors. Following an investor day event the firm describes as " straight down the fairway," it adds that the company's new targets reflect the more durable favorable environment in "what we see as the 'golden age' of drug distribution."
BofA
Allen Lutz
Buy
maintain
$170 -> $180
2025-06-13
New
Reason
BofA
Allen Lutz
Price Target
$170 -> $180
2025-06-13
New
maintain
Buy
Reason
BofA analyst Allen Lutz raised the firm's price target on Cardinal Health to $180 from $170 and keeps a Buy rating on the shares. After having attended Cardinal Health's investor day, the firm came away from the event "incrementally confident" in management's strategy, internal investments the company is making and capital allocation, the analyst tells investors. Following the event, the firm applies a higher multiple to its estimates, driven by stronger EBIT growth and cash flow generation.
Evercore ISI
Outperform
maintain
$175 -> $180
2025-06-12
Reason
Evercore ISI
Price Target
$175 -> $180
2025-06-12
maintain
Outperform
Reason
Evercore ISI raised the firm's price target on Cardinal Health to $180 from $175 and keeps an Outperform rating on the shares after attending the company's Investor Day event. Cardinal's long-term guidance remains unchanged, and Evercore ISI sees continued potential upside to the firm's estimates given the company's strong execution, deployment of improved free cash flow, and multipronged growth outlook with particular potential upside from specialty, nuclear/other, the analyst tells investors in a research note.
BofA
Buy
maintain
$165 -> $170
2025-06-10
Reason
BofA
Price Target
$165 -> $170
2025-06-10
maintain
Buy
Reason
BofA raised the firm's price target on Cardinal Health to $170 from $165 and keeps a Buy rating on the shares ahead of the company's upcoming investor day on June 12. Expectations are high heading into the event due to "impressive execution over the past two years and multiple industry tailwinds," says the analyst, who increases the firm's target to reflect higher peer multiples. The firm expects Cardinal Health to raise its long-term target Pharmaceutical EBIT growth guidance from 4-6% to 5-7% or 5-8%, the analyst noted.
Wells Fargo
Stephen Baxter
Equal Weight -> Overweight
upgrade
$136 -> $179
2025-06-03
Reason
Wells Fargo
Stephen Baxter
Price Target
$136 -> $179
2025-06-03
upgrade
Equal Weight -> Overweight
Reason
Wells Fargo analyst Stephen Baxter upgraded Cardinal Health to Overweight from Equal Weight with a price target of $179, up from $136.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Cardinal Health Inc (CAH.N) is 17.22, compared to its 5-year average forward P/E of 12.03. For a more detailed relative valuation and DCF analysis to assess Cardinal Health Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average PE
12.03
Current PE
17.22
Overvalued PE
14.43
Undervalued PE
9.62

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average EV/EBITDA
8.20
Current EV/EBITDA
12.04
Overvalued EV/EBITDA
9.40
Undervalued EV/EBITDA
7.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average PS
0.10
Current PS
0.15
Overvalued PS
0.12
Undervalued PS
0.08

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress areBuying! The buying amount has increased200%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

CAH News & Events

Events Timeline

(ET)
2025-06-12
07:09:24
Cardinal Health sees FY26-FY28 EPS up 12%-14%
select
2025-06-12
07:07:24
Cardinal Health sees FY26 EPS $9.10-$9.30, consensus $9.13
select
2025-06-12
07:05:42
Cardinal Health raises FY25 EPS view to $8.15-$8.20 from $8.05-$8.15
select
Sign Up For More Events
Sign Up For More Events

News

Preview
7.0
06-13Reuters
Cardinal Health boosts profit view banking on specialty drugs unit growth

  • Cardinal Health's Profit Forecast: Cardinal Health raised its annual adjusted profit forecast, expecting a growth of 12% to 13% in its specialty medicines unit for fiscal 2025, driven by strong demand for expensive specialty and branded drugs.

  • Impact of Tariffs: The company anticipates a $200 million to $300 million hit to its fiscal 2026 profit due to U.S.-China tariffs, but plans to work with customers on price increases and other solutions to mitigate the impact.

Preview
4.5
06-13NASDAQ.COM
Stocks Settle Higher as Bond Yields Fall on Fed-Friendly US Economic News

  • Market Performance: The S&P 500, Dow Jones, and Nasdaq all closed higher on Thursday, recovering from earlier losses due to favorable US jobless claims and PPI reports that lowered bond yields and increased expectations for Fed rate cuts. However, geopolitical tensions and trade uncertainties, particularly regarding tariffs, continue to pose risks to market stability.

  • Stock Movements: Notable stock movements included Oracle rising over 13% after strong earnings, while GameStop fell more than 22% following a convertible notes offering. Airline stocks faced pressure due to declining airfare prices, and Boeing and GE Aerospace dropped after a Boeing 787 Dreamliner crash in India.

Preview
4.0
06-13Benzinga
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $180

  • Real-time Intelligence for Traders: Benzinga Pro offers the fastest news alerts and real-time intelligence to help traders succeed in the stock market.

  • Exclusive Community Access: Joining Benzinga Pro connects you with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Cardinal Health Inc (CAH) stock price today?

The current price of CAH is 164.91 USD — it has increased 1.54 % in the last trading day.

arrow icon

What is Cardinal Health Inc (CAH)'s business?

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

arrow icon

What is the price predicton of CAH Stock?

Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 171.42 USD with a low forecast of 156.00 USD and a high forecast of 183.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Cardinal Health Inc (CAH)'s revenue for the last quarter?

Cardinal Health Inc revenue for the last quarter amounts to 54.88B USD, increased 0.02 % YoY.

arrow icon

What is Cardinal Health Inc (CAH)'s earnings per share (EPS) for the last quarter?

Cardinal Health Inc. EPS for the last quarter amounts to 2.10 USD, increased 96.26 % YoY.

arrow icon

What changes have occurred in the market's expectations for Cardinal Health Inc (CAH)'s fundamentals?

The market is revising Upward the revenue expectations for Cardinal Health, Inc. (CAH) for FY2025, with the revenue forecasts being adjusted by 0.08% over the past three months. During the same period, the stock price has changed by 26.82%.
arrow icon

How many employees does Cardinal Health Inc (CAH). have?

Cardinal Health Inc (CAH) has 48900 emplpoyees as of June 18 2025.

arrow icon

What is Cardinal Health Inc (CAH) market cap?

Today CAH has the market capitalization of 39.36B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free